Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry.
Saved in:
| Title: | Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry. |
|---|---|
| Authors: | Annunziato S; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Quan C; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Donckele EJ; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Lamberto I; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Bunker RD; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Zlotosch M; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Schwander L; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Murthy A; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Wiedmer L; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Staehly C; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Matysik M; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Gilberto S; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Kapsitidou D; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Wible D; Monte Rosa Therapeutics, Inc., Boston, MA, USA., De Donatis GM; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Trenh P; Monte Rosa Therapeutics, Inc., Boston, MA, USA., SriRamaratnam R; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Strande V; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Lieberherr R; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Lyon D; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Steiner D; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Silva J; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Almeida R; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Dolgikh E; Monte Rosa Therapeutics, Inc., Boston, MA, USA., DeMarco B; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Tsai J; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Sadok A; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Zarayskiy V; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Walter M; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Tiedt R; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Lumb KJ; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Bonenfant D; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Fasching B; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Castle JC; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Townson SA; Monte Rosa Therapeutics, Inc., Boston, MA, USA., Gainza P; Monte Rosa Therapeutics, Inc., Boston, MA, USA. pgainza@monterosatx.com., Petzold G; Monte Rosa Therapeutics, Inc., Boston, MA, USA. gpetzold@monterosatx.com. |
| Source: | Nature structural & molecular biology [Nat Struct Mol Biol] 2026 Mar; Vol. 33 (3), pp. 479-487. Date of Electronic Publication: 2026 Jan 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101186374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-9985 (Electronic) Linking ISSN: 15459985 NLM ISO Abbreviation: Nat Struct Mol Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
